European Commission Grants Conditional Marketing Authorization for Gilead’s Veklury for the Treatment of COVID-19
Gilead Sciences today announced that the European Commission has granted conditional marketing authorization for Veklury (remdesivir) as a treatment for...
Appeals Court Affirms Validity of Enbrel Patents Injunction Against Sandoz’s Infringement Stands
Amgen today announced that the US Court of Appeals for the Federal Circuit has held in Amgen's favor on the...
Aptose Announces FDA Allowance of IND for Phase 1a/b Study of CG-806 in Acute Myeloid Leukemia
Aptose Biosciences announced that the US Food and Drug Administration completed its review of the company’s investigational new drug (IND)...
An Open Letter from Daniel O’Day, Chairman and CEO, Gilead Sciences
In the weeks since we learned of remdesivir’s potential against COVID-19, one topic has attracted more speculation than any other:...
European Commission Approves Reblozyl for the Treatment of Transfusion-dependent Anemia
Reblozyl regulates late-stage red blood cell maturation to potentially reduce or eliminate the need for regular RBC transfusions.
Portage Announces Results of Annual Meeting; Private Placement Update; Corporate Update
Portage Biotech is very pleased to announce the results of its annual meeting of shareholders held on June 25, 2020.
Allergan and Molecular Partners Receive Complete Response Letter from FDA on Biologics License Application
Allergan announced that the US Food and Drug Administration has issued a complete response letter to the biologics license application...